| Trial ID: | L0455 |
| Source ID: | ChiCTR1900025938
|
| Associated Drug: |
FTZ
|
| Title: |
A randomized, double-blind, placebo-controlled clinical study for FTZ in the treatment of patients with nonalcoholic fatty liver disease
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic fatty liver disease
|
| Interventions: |
Experimental Group:FTZ 4 capsules each time (2.52g), 3 times a day;Control group:FTZ simulant 4 capsules per time, 3 times a day;
|
| Outcome Measures: |
At 12th, 24th Week, Magnetic resonance examination resonance examination of changes in liver fat content;Absolute fat change index change at the 12th and 24th weekend;Absolute value of liver hardness change at the 12th and 24th weekend;Absolute value of blood lipids (TC, TG, LDL) at the 12th and 24th weekend;Absolute value of blood glucose change 2 hours after meal on the 12th and 24th weekend;Absolute value of HOMA-IR index at the 12th and 24th weekend;Absolute change in body mass index at the 12th and 24th weekend;The absolute value of waist and hip circumference change at the 12th and 24th weekend;Absolute value of body fat percentage change at the 12th and 24th weekend;the scores of TCM Syndrome;the scores of single TCM symptom;
|
| Sponsor/Collaborators: |
The First Affiliated Hospital of Guangdong Pharmaceutical University
|
| Gender: |
All
|
| Age: |
3565
|
| Phases: |
Not applicable
|
| Enrollment: |
Experimental Group:40;Control group:40;
|
| Study Type: |
Interventional study
|
| Study Designs: |
Parallel
|
| Start Date: |
15/09/2019
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
16 September 2019
|
| Locations: |
China
|
| URL: |
http://www.chictr.org.cn/showproj.aspx?proj=42791
|
